Literature DB >> 26733048

Isoxazolines: A Novel Chemotype Highly Effective on Ectoparasites.

Tina Weber1, Paul M Selzer2,3,4.   

Abstract

Efficient control of arthropod ectoparasite infestations has a long-standing history in the agriculture and veterinary sectors, aiming to decrease the parasite burden of affected crops and animals. Ligand-gated chloride channels (LGCCs) modulated by γ-aminobutyric acid (GABA) and glutamate have been identified as suitable molecular targets, and several classes of potent parasiticides have been devised. Due to the increase in cross-resistance and decreased development of new chemical entities, an urgent need for new parasiticides or prevention schemes has emerged. In the last decade, an innovative isoxazoline chemotype appears to offer promise for inhibiting LGCCs with a new mode of action and distinct binding site from that of historical agents. Considerable efforts have focused on optimizing the antiparasitic activity of isoxazolines and may provide the potential for future human use.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  arthropod-borne diseases; drug discovery; ectoparasiticides; ion channels; isoxazolines

Mesh:

Substances:

Year:  2016        PMID: 26733048     DOI: 10.1002/cmdc.201500516

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  15 in total

1.  Efficacy and Pharmacokinetics Evaluation of a Single Oral Dose of Afoxolaner against Sarcoptes scabiei in the Porcine Scabies Model for Human Infestation.

Authors:  Charlotte Bernigaud; Fang Fang; Olivier Chosidow; Jacques Guillot; Katja Fischer; Anne Lespine; Ludwig S Aho; Amanda J Mullins; Berhane Tecle; Andrew Kelly; Jean-François Sutra; Francis Moreau; Thomas Lilin; Frédéric Beugnet; Françoise Botterel
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

2.  Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases.

Authors:  Marie Miglianico; Maarten Eldering; Hannah Slater; Neil Ferguson; Pauline Ambrose; Rosemary S Lees; Karin M J Koolen; Katerina Pruzinova; Magdalena Jancarova; Petr Volf; Constantianus J M Koenraadt; Hans-Peter Duerr; Graham Trevitt; Baiyuan Yang; Arnab K Chatterjee; John Wisler; Angelika Sturm; Teun Bousema; Robert W Sauerwein; Peter G Schultz; Matthew S Tremblay; Koen J Dechering
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-02       Impact factor: 11.205

Review 3.  Heartworm disease - Overview, intervention, and industry perspective.

Authors:  Sandra Noack; John Harrington; Douglas S Carithers; Ronald Kaminsky; Paul M Selzer
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2021-04-27       Impact factor: 4.077

Review 4.  A rapid evidence assessment of the potential risk to the environment presented by active ingredients in the UK's most commonly sold companion animal parasiticides.

Authors:  Clodagh Wells; C M Tilly Collins
Journal:  Environ Sci Pollut Res Int       Date:  2022-04-24       Impact factor: 5.190

5.  Evolution, Expression, and Function of Nonneuronal Ligand-Gated Chloride Channels in Drosophila melanogaster.

Authors:  Emily J Remnant; Adam Williams; Chris Lumb; Ying Ting Yang; Janice Chan; Sebastian Duchêne; Phillip J Daborn; Philip Batterham; Trent Perry
Journal:  G3 (Bethesda)       Date:  2016-07-07       Impact factor: 3.154

Review 6.  Blocking transmission of vector-borne diseases.

Authors:  Sandra Schorderet-Weber; Sandra Noack; Paul M Selzer; Ronald Kaminsky
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-01-30       Impact factor: 4.077

7.  A single oral dose of fluralaner (Bravecto®) in dogs rapidly kills 100% of blood-fed Phlebotomus perniciosus, a main visceral leishmaniasis vector, for at least 1 month after treatment.

Authors:  G Bongiorno; L Meyer; A Evans; N Lekouch; R Bianchi; C Khoury; R Chiummo; E Thomas; L Gradoni
Journal:  Med Vet Entomol       Date:  2019-11-26       Impact factor: 2.739

8.  Suspected neurological toxicity after oral application of fluralaner (Bravecto®) in a Kooikerhondje dog.

Authors:  Daniela Gaens; Christoph Rummel; Martin Schmidt; Melanie Hamann; Joachim Geyer
Journal:  BMC Vet Res       Date:  2019-08-07       Impact factor: 2.741

9.  Laboratory evaluation of the efficacy and speed of kill of lotilaner (CredelioTM) against Ixodes ricinus ticks on cats.

Authors:  Daniela Cavalleri; Martin Murphy; Wolfgang Seewald; Jason Drake; Steve Nanchen
Journal:  Parasit Vectors       Date:  2018-07-13       Impact factor: 3.876

10.  A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling fleas in client-owned cats in Europe.

Authors:  Daniela Cavalleri; Martin Murphy; Wolfgang Seewald; Steve Nanchen
Journal:  Parasit Vectors       Date:  2018-07-13       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.